Trials / Not Yet Recruiting

Not Yet RecruitingNCT06476301

Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves

Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves: A Prospective, Randomized, Controlled Non-Inferiority Trial

Status: Not Yet Recruiting
Phase: Phase 4
Study type: Interventional
Enrollment: 250 (estimated)

Sponsor: RenJi Hospital · Academic / Other
Sex: All
Age: 18 Years – 80 Years
Healthy volunteers: Not accepted

Summary

this study aims to comprehensively evaluate the efficacy and safety profiles of rivaroxaban and warfarin during the initial postoperative period following surgical bioprosthetic valve in patients.

Conditions

Anticoagulation

Interventions

Type	Name	Description
DRUG	Rivaroxaban	To compare the efficacy and safety of rivaroxaban as an early anticoagulant therapy for BPV patients with the traditional postoperative anticoagulant warfarin

Timeline

Start date: 2024-08-01
Primary completion: 2026-02-28
Completion: 2026-12-31
First posted: 2024-06-26
Last updated: 2024-06-28

Source: ClinicalTrials.gov record NCT06476301. Inclusion in this directory is not an endorsement.